Free Newsletter
Nanotubes superior at delivering chemotherapy
Tiny nanotubes were used to precisely deliver a concentrated payload of chemotherapy directly to the site of a tumor, according to a team of scientists at Stanford University. By sizing the nanotubes to slip through tumor tissue while being blocked by the walls of healthy blood vessels, the researchers say that the new approach avoids the harsh side effects usually associated with chemotherapy. And after 22 days of treatment the mice in the nanotube group had tumors half the size of the tumors in mice being treated with a standard chemotherapy. The breakthrough could also allow physicians to significantly reduce doses of chemotherapy.
"We are definitely hoping to be able to push this to practical applications into the clinic," chemistry professor Hongjie Dai told the San Jose Mercury News.
--read the report in the San Jose Mercury News
Related Articles:
Nanotech grows more common in drug dev research
FDA to gather more info on bio-nano
Drug delivery vehicles' shape could determine efficacy
Venture capitalists bet big on nanotechnology
Fat bubbles used to deliver chemo
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




